(Q42443959)

31 October 2017

title

Mortality after deferral of treatment or no treatment for choroidal melanoma. (English)

1 reference

Collaborative Ocular Melanoma Study Group

31 October 2017

2

Marie Diener-West

0 references

series ordinal

5

object named as

Collaborative Ocular Melanoma Study Group

1 reference

31 October 2017

1

Bradley R Straatsma

1 reference

31 October 2017

Robert Caldwell

3

1 reference

31 October 2017

Robert E Engstrom

series ordinal

4

1 reference

31 October 2017

language of work or name

English

0 references

publication date

1 July 2003

1 reference

American Journal of Ophthalmology

31 October 2017

published in

1 reference

31 October 2017

volume

136

1 reference

31 October 2017

issue

1

1 reference

31 October 2017

page(s)

47-54

1 reference

Radiotherapy for malignant melanoma of the choroid

31 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2902270-5

Radiotherapy of choroidal melanoma with iodine-125

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2902270-5

Proton beam irradiation of uveal melanomas. Results of 5 1/2-year study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2902270-5

Helium ion therapy for choroidal melanoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2902270-5

Cobalt plaque therapy of posterior uveal melanomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2902270-5

The Preservation of Vision by Treatment of Intraocular Tumors with Light Coagulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2902270-5

Alternatives to enucleation in the management of choroidal melanoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2902270-5

Primary transpupillary thermotherapy for small choroidal melanoma in 256 consecutive cases: outcomes and limitations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2902270-5

Impact of delayed treatment in growing posterior uveal melanomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2902270-5

Design and methods of a clinical trial for a rare condition: the Collaborative Ocular Melanoma Study. COMS Report No. 3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2902270-5

Enucleation versus plaque irradiation for choroidal melanoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2902270-5

The Collaborative Ocular Melanoma Study (COMS) randomized trial of pre-enucleation radiation of large choroidal melanoma I: characteristics of patients enrolled and not enrolled COMS report no. 9

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2902270-5

The Collaborative Ocular Melanoma Study (COMS) randomized trial of pre-enucleation radiation of large choroidal melanoma II: initial mortality findings COMS report no. 10

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2902270-5

The Collaborative Ocular Melanoma Study (COMS) randomized trial of pre-enucleation radiation of large choroidal melanoma III: local complications and observations following enucleation COMS report no. 11

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2902270-5

The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma, II: characteristics of patients enrolled and not enrolled. COMS Report No. 17.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2902270-5

The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma, III: initial mortality findings. COMS Report No. 18

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2902270-5

Nonparametric Estimation from Incomplete Observations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2902270-5

Histopathologic characteristics of uveal melanomas in eyes enucleated from the collaborative ocular melanoma study COMS report no. 6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2902270-5

A rapidly growing choroidal melanoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2902270-5

Extremely rapid growth of a primary choroidal melanoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2902270-5

The natural history of uveal melanomas and its therapeutic consequences

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2902270-5

Uveal melanoma: updated considerations on current management modalities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2902270-5

Tumor doubling times in metastatic malignant melanoma of the uvea: tumor progression before and after treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2902270-5

Melanomas, metastases, and survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2902270-5

Cytogenetic findings in six posterior uveal melanomas: involvement of chromosomes 3, 6, and 8.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2902270-5

Nonrandom chromosomal abnormalities in primary uveal melanoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2902270-5

Non-random abnormalities of chromosomes 3, 6, and 8 associated with posterior uveal melanoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2902270-5

Immunosensitization of melanoma tumor cells to non-MHC Fas-mediated killing by MART-1-specific CTL cultures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2902270-5

10.1016/S0002-9394(02)02270-5

7 January 2021

Identifiers

DOI

1 reference

31 October 2017

1 reference